publicaciones seleccionadas
-
documento
- HSD105 Cost Savings Benefits of Operational Waste Minimization in a Care Program by Cohorts of Babies on Treatment With Palivizumab 2022-12
- HSD23 Operational Waste Savings on Health in a Value-Based Patient Drug Safety Program 2022-12
- HSD69 Cost Savings of Waste on Health by Pharmacological Inefficiencies in a Value-Based Patient Drug Safety Program 2022-12
- HSD92 Operational Savings Generated in an Integrated Care Clinic for Immune-Mediated Skin Disorders 2022-12
- Descripción de los factores de riesgo relacionados a las fracturas por fragilidad en adultos y sus costos asociados 2022-03-09
- Identification and differentiation of underivatized diasteromeric mono-and disaccharides by ESI-IT-MS/MS,Identificación y diferenciación de monosacáridos y disacáridos diasteroméricos no derivatizados por ESI-IT-MS/MS 2010
- Aspectos farmacológicos y adherencia al tratamiento antirretroviral en pacientes VIH
- INCIDENCE AND ASSOCIATED FACTORS WITH THE CHANGE FREE TIME BETWEEN THE BRANDED OR GENERIC IMATINIB IN NAIVE PATIENTS WITH CHRONIC MYELOID LEUKEMIA
- Prevalence, associated causes, and explanatory variables of non-adherence of generic imatinib in chronic myeloid leukemia